% in the Bypass vs Angioplasty in Severe
Ischaemia of the Leg (BASIL) trial,24-26 64% in the Project
of Ex-Vivo Vein Graft Engineering via Transfection III
(PREVENT III) trial,27 and exceeds 70% to 80% in many
specialized vascular centers.28,29 Although tradition teaches
that the initiating cause of foot ulceration in